Marisa R Nucci

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi Distinctive cytogenetic profile in benign metastasizing leiomyoma: pathogenetic implications
    Marisa R Nucci
    Department of Pathology, Divisions of Women s and Perinatal Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Am J Surg Pathol 31:737-43. 2007
  2. ncbi Redefining early cervical neoplasia: recent progress
    Marisa R Nucci
    Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital, Boston, MA 02445, USA
    Adv Anat Pathol 14:1-10. 2007
  3. ncbi Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms
    Marisa R Nucci
    Division of Molecular Oncology, Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
    Am J Surg Pathol 31:65-70. 2007
  4. ncbi Arias-Stella reaction of the endocervix: a report of 18 cases with emphasis on its varied histology and differential diagnosis
    Marisa R Nucci
    Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Am J Surg Pathol 28:608-12. 2004
  5. ncbi Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications
    Joseph W Carlson
    Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Int J Gynecol Pathol 29:310-4. 2010
  6. ncbi Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance
    Elke A Jarboe
    Department of Pathology, Division of Women s and Perinatal Pathology, Brigham and Women s Hospital, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Int J Gynecol Pathol 28:308-15. 2009
  7. ncbi Clinical outcome in diagnostically ambiguous foci of 'gland crowding' in the endometrium
    Eric C Huang
    Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Mod Pathol 23:1486-91. 2010
  8. ncbi Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria
    Dana R Semmel
    Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Mod Pathol 22:985-8. 2009
  9. ncbi Histologic and immunohistochemical decision-making in endometrial adenocarcinoma
    Lesley Lomo
    Department of Pathology, Division of Women s and Perinatal Pathology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Mod Pathol 21:937-42. 2008
  10. ncbi Biomarkers in diagnostic obstetric and gynecologic pathology: a review
    Marisa R Nucci
    Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachussetts 02115, USA
    Adv Anat Pathol 10:55-68. 2003

Collaborators

Detail Information

Publications33

  1. ncbi Distinctive cytogenetic profile in benign metastasizing leiomyoma: pathogenetic implications
    Marisa R Nucci
    Department of Pathology, Divisions of Women s and Perinatal Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Am J Surg Pathol 31:737-43. 2007
    ....
  2. ncbi Redefining early cervical neoplasia: recent progress
    Marisa R Nucci
    Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital, Boston, MA 02445, USA
    Adv Anat Pathol 14:1-10. 2007
    ..In addition, practical issues in the diagnosis and management of squamous epithelial lesions, particularly the recognition of nonconventional variants and the application of biomarkers, are discussed...
  3. ncbi Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms
    Marisa R Nucci
    Division of Molecular Oncology, Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
    Am J Surg Pathol 31:65-70. 2007
    ..In addition, the detection of the fusion by reverse transcriptase-polymerase chain reaction or FISH for JJAZ1 at 7p15 may be diagnostically useful...
  4. ncbi Arias-Stella reaction of the endocervix: a report of 18 cases with emphasis on its varied histology and differential diagnosis
    Marisa R Nucci
    Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Am J Surg Pathol 28:608-12. 2004
    ....
  5. ncbi Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications
    Joseph W Carlson
    Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Int J Gynecol Pathol 29:310-4. 2010
    ..In view of these findings, a diagnosis of STIC should be corroborated by a second pathologist, if feasible...
  6. ncbi Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance
    Elke A Jarboe
    Department of Pathology, Division of Women s and Perinatal Pathology, Brigham and Women s Hospital, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Int J Gynecol Pathol 28:308-15. 2009
    ....
  7. ncbi Clinical outcome in diagnostically ambiguous foci of 'gland crowding' in the endometrium
    Eric C Huang
    Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Mod Pathol 23:1486-91. 2010
    ..It underscores the importance of follow-up when some but not all of the criteria for EIN are encountered in the appropriate clinical setting...
  8. ncbi Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria
    Dana R Semmel
    Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Mod Pathol 22:985-8. 2009
    ..The rationale for this strategy, and its potential effect on early detection and in uncovering persons or families potentially at risk for ovarian cancer, is discussed...
  9. ncbi Histologic and immunohistochemical decision-making in endometrial adenocarcinoma
    Lesley Lomo
    Department of Pathology, Division of Women s and Perinatal Pathology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Mod Pathol 21:937-42. 2008
    ..Because p53 is an important marker for endometrial adenocarcinoma outcome, and cannot be predicted in advance in indeterminate cases, p53 immunostaining should be employed in cases with observer disagreement in a binary system...
  10. ncbi Biomarkers in diagnostic obstetric and gynecologic pathology: a review
    Marisa R Nucci
    Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachussetts 02115, USA
    Adv Anat Pathol 10:55-68. 2003
    ....
  11. ncbi Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors
    Martin C Chang
    Department of Pathology, Division of Women s and Perinatal Pathology, Brigham and Women s Hospital, Children s Hospital Boston, Massachusetts 02115, USA
    Int J Gynecol Pathol 28:347-55. 2009
    ..The inclusion of these markers should therefore be considered in cases of pure or mixed ovarian germ cell tumors that are difficult to classify, and to exclude nongerm cell tumor mimics...
  12. ncbi High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression
    Michael H Roh
    Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA
    Mod Pathol 23:1316-24. 2010
    ..PAX2 and PTEN, in addition to p53 and p16(ink4), comprise a potentially important gene combination in high-grade pelvic carcinogenesis...
  13. ncbi Adenofibroma of the fimbria: a common entity that is indistinguishable from ovarian adenofibroma
    Veerle Bossuyt
    Department of Pathology, Division of Women s and Perinatal Pathology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Int J Gynecol Pathol 27:390-7. 2008
    ..Whether the shared tumor phenotype in these 2 organs is coincidental or interdependent bears further investigation...
  14. ncbi The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis
    Alessandra F Nascimento
    Department of Pathology, Division of Women's and Perinatal Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    Mod Pathol 16:22-7. 2003
    ..In contrast, absence of CD10 expression excludes involvement of adenomyosis by adenocarcinoma...
  15. ncbi Fallopian tube correlates of ovarian serous borderline tumors
    Anna R Laury
    Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Am J Surg Pathol 35:1759-65. 2011
    ..Further study is warranted to clarify the relationship of the oviduct to serous neoplasia...
  16. ncbi Meningothelial proliferations in mature cystic teratoma of the ovary: evidence for the common presence of cranially derived tissues paralleling anterior embryonic plate development. An analysis of 25 consecutive cases
    Eleanor Chen
    Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Am J Surg Pathol 34:1014-8. 2010
    ....
  17. ncbi Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity
    Brooke E Howitt
    Department of Pathology, Division of Women s and Perinatal Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Am J Surg Pathol 37:89-97. 2013
    ..Further studies correlating STMN staining with lesion persistence or morphologic progression, in the context of CIN grade, are warranted...
  18. ncbi Peritoneal dissemination complicating morcellation of uterine mesenchymal neoplasms
    Michael A Seidman
    Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital Harvard Medical School, Boston, Massachussetts, United States of America
    PLoS ONE 7:e50058. 2012
    ..This study was undertaken to determine the frequency and clinical consequence of intraperitoneal dissemination of these neoplasms...
  19. ncbi Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion
    Charles M Quick
    Department of Pathology, Brigham and Women s Hospital, Boston, MA, USA
    Int J Gynecol Pathol 31:337-43. 2012
    ....
  20. ncbi A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer
    Michael Herfs
    Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Proc Natl Acad Sci U S A 109:10516-21. 2012
    ....
  21. ncbi Atypical genital nevi. A clinicopathologic analysis of 56 cases
    Briana C Gleason
    Department of Pathology, Brigham and Women s Hospital, Boston, MA, USA
    Am J Surg Pathol 32:51-7. 2008
    ..Awareness and recognition of this group of melanocytic lesions is important to avoid over diagnosis as melanoma with subsequent wide excision and possibly sentinel lymph node biopsy...
  22. ncbi Serous carcinogenesis in the fallopian tube: a descriptive classification
    Elke Jarboe
    Department of Pathology, Division of Women s and Perinatal Pathology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Int J Gynecol Pathol 27:1-9. 2008
    ..Combined with recent reports associating STICs with pelvic serous cancer, this continuum of epithelial change validates the SCAT sequence and the fimbrial secretory cell as the site of origin for many serous carcinomas...
  23. ncbi Hertig and beyond: a systematic and practical approach to the endometrial biopsy
    Christopher P Crum
    Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Adv Anat Pathol 10:301-18. 2003
    ..Algorithms for the laboratory management of cyclic changes, dysfunctional bleeding, and mixed-pattern endometria are provided, as are pitfalls in interpretation and exclusion of neoplasia...
  24. ncbi The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor
    Cheng Han Lee
    Department of Pathology, Brigham and Women s Hospital, Boston, MA, USA
    Am J Surg Pathol 36:641-53. 2012
    ..Thus, their distinction from typical JAZF1 ESS is important for prognostic and therapeutic purposes...
  25. ncbi Fertility-sparing treatment in younger women with adenocarcinoma in situ of the cervix
    Nehalennia VAN Hanegem
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women s Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
    Gynecol Oncol 124:72-7. 2012
    ..In women who desire future fertility, however, conservative therapy is an acceptable alternative. In this study we compare the outcomes for young women who underwent loop conization or were treated with cold knife conization...
  26. ncbi Symposium part III: tumor-like glandular lesions of the uterine cervix
    Marisa R Nucci
    Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    Int J Gynecol Pathol 21:347-59. 2002
    ..The entities that will be discussed include tunnel clusters, microglandular hyperplasia, mesonephric hyperplasia, endocervical glandular hyperplasia, and the Arias-Stella reaction...
  27. ncbi Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma
    Chandrajit P Raut
    Department of Surgery, Brigham and Women s Hospital, Dana Farber Cancer Institute, Harvard Medical School, 75 Francis Street, Boston, MA 02115, United States
    Eur J Cancer 45:2818-24. 2009
    ..Neither has been validated in ULMS. We critically evaluated both systems to determine if either identified patient groups with distinct outcomes...
  28. ncbi Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study
    Diego H Castrillon
    Women's and Perinatal Pathology Division, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    Int J Gynecol Pathol 21:4-10. 2002
    ..EMA positivity was present in all 30 EMCAs and in 26 of 29 (90%) CCAs. We conclude that VIM and CEA are useful immunohistochemical markers in distinguishing EMCAs and CCAs, but CK7, CK20, and EMA are not useful in this distinction...
  29. ncbi Ovarian mucinous and mixed epithelial carcinomas of mullerian (endocervical-like) type: a clinicopathologic analysis of four cases of an uncommon variant associated with endometriosis
    Kenneth R Lee
    Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    Int J Gynecol Pathol 22:42-51. 2003
    ..To better understand their clinicopathologic features and pathogenesis, this uncommon variant should be separated from the usual type in future studies of mucinous carcinomas of the ovary...
  30. ncbi Fallopian tube prolapse mimicking aggressive angiomyxoma
    Heike Varnholt
    Department of Pathology, Baystate Medical Center, Tufts University School of Medicine, Springfield, Massachusetts 01199, USA
    Int J Gynecol Pathol 24:292-4. 2005
    ..Condensation of eosinophilic fibrils around medium sized vessels was marked. This case of fallopian tube prolapse shows an unusual resemblance of aggressive angiomyxoma and thus poses a diagnostic pitfall...
  31. ncbi Complete hydatidiform mole retaining a chromosome 11 of maternal origin: molecular genetic analysis of a case
    Rosemary A Fisher
    Department of Cancer Medicine, Faculty of Medicine, Imperial College London, Charing Cross Hospital, London, UK
    Mod Pathol 17:1155-60. 2004
    ..Furthermore, these results provide an explanation for rare false negatives that can arise when p57(KIP2) is used as a diagnostic marker for complete moles...
  32. ncbi Ewing family of tumours involving the vulva and vagina: report of a series of four cases
    W Glenn McCluggage
    Department of Pathology, Royal Group of Hospitals Trust, Belfast, Northern Ireland
    J Clin Pathol 60:674-80. 2007
    ..In this study, four new cases of EFTs involving the vulva (three cases) or vagina (one case) are reported...
  33. ncbi Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies
    James V Lacey
    Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland 20852 7234, USA
    Cancer 113:2073-81. 2008
    ..The authors estimated progression risk associated with EIN among endometrial biopsies in a nested case-control study of EH progression...